Search Results 351-360 of 15285 for CLL

  1. Exploring The Role Of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) In BAFFR-expressing B-cell Hematologic Malignancies And Autoimmune Rheumatologic Disorders - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL) and B-cell acute lymphoblastic leukemia (B-cell ALL) using primary tumor and/or patient derived xenograft models, and to ...

  2. Cholecalciferol In Improving Survival In Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency - Mayo Clinic

    Newly diagnosed aggressive lymphoma or CLL/small lymphocytic lymphoma (SLL) that meets disease specific criteria below: Study 1 - Aggressive lymphoma. Newly ...

  3. Clinical trials - Oncology (Medical)

    A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

  4. Fludarabine (intravenous route) - Side effects & uses - Mayo Clinic

    It is used to treat a type of cancer of the white blood cells called B-cell chronic lymphocytic leukemia (CLL). This medicine is used in patients with CLL ...

  5. Bone Marrow Transplant Program - Clinical trials

    ... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy control (HC) donors. A Study To Evaluate The Role Of Gut Microbiome In Cancer ...

  6. Jose F. Leis, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    MemberChronic Lymphocytic Leukemia Core Group (CLL), Division of Hematology/Oncology, Department of Internal Medicine. 2007 - present. MemberMayo Clinic ...

  7. Oncology (Medical) - Clinical trials - Mayo Clinic

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...

  8. Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer.

  9. Clinical trials - Oncology (Medical)

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  10. Clinical trials - Oncology (Medical)

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...